These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Benzimidazole- and benzoxazole-based inhibitors of Rho kinase. Sessions EH; Yin Y; Bannister TD; Weiser A; Griffin E; Pocas J; Cameron MD; Ruiz C; Lin L; Schürer SC; Schröter T; LoGrasso P; Feng Y Bioorg Med Chem Lett; 2008 Dec; 18(24):6390-3. PubMed ID: 18996009 [TBL] [Abstract][Full Text] [Related]
8. Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors. Kopecky DJ; Hao X; Chen Y; Fu J; Jiao X; Jaen JC; Cardozo MG; Liu J; Wang Z; Walker NP; Wesche H; Li S; Farrelly E; Xiao SH; Kayser F Bioorg Med Chem Lett; 2008 Dec; 18(24):6352-6. PubMed ID: 18993068 [TBL] [Abstract][Full Text] [Related]
9. 2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocket. Lo HY; Bentzien J; Fleck RW; Pullen SS; Khine HH; Woska JR; Kugler SZ; Kashem MA; Takahashi H Bioorg Med Chem Lett; 2008 Dec; 18(23):6218-21. PubMed ID: 18930400 [TBL] [Abstract][Full Text] [Related]
10. Optimization of 2-phenylaminoimidazo[4,5-h]isoquinolin-9-ones: orally active inhibitors of lck kinase. Goldberg DR; Butz T; Cardozo MG; Eckner RJ; Hammach A; Huang J; Jakes S; Kapadia S; Kashem M; Lukas S; Morwick TM; Panzenbeck M; Patel U; Pav S; Peet GW; Peterson JD; Prokopowicz AS; Snow RJ; Sellati R; Takahashi H; Tan J; Tschantz MA; Wang XJ; Wang Y; Wolak J; Xiong P; Moss N J Med Chem; 2003 Apr; 46(8):1337-49. PubMed ID: 12672234 [TBL] [Abstract][Full Text] [Related]
11. Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity. Kirrane TM; Boyer SJ; Burke J; Guo X; Snow RJ; Soleymanzadeh L; Swinamer A; Zhang Y; Madwed JB; Kashem M; Kugler S; O'Neill MM Bioorg Med Chem Lett; 2012 Jan; 22(1):738-42. PubMed ID: 22056746 [TBL] [Abstract][Full Text] [Related]
13. Discovery of pyrimidine benzimidazoles as Lck inhibitors: part I. Zhang G; Ren P; Gray NS; Sim T; Liu Y; Wang X; Che J; Tian SS; Sandberg ML; Spalding TA; Romeo R; Iskandar M; Chow D; Martin Seidel H; Karanewsky DS; He Y Bioorg Med Chem Lett; 2008 Oct; 18(20):5618-21. PubMed ID: 18793846 [TBL] [Abstract][Full Text] [Related]
14. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics. Dang Q; Kasibhatla SR; Xiao W; Liu Y; Dare J; Taplin F; Reddy KR; Scarlato GR; Gibson T; van Poelje PD; Potter SC; Erion MD J Med Chem; 2010 Jan; 53(1):441-51. PubMed ID: 20055427 [TBL] [Abstract][Full Text] [Related]
16. Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors. Charrier JD; Miller A; Kay DP; Brenchley G; Twin HC; Collier PN; Ramaya S; Keily SB; Durrant SJ; Knegtel RM; Tanner AJ; Brown K; Curnock AP; Jimenez JM J Med Chem; 2011 Apr; 54(7):2341-50. PubMed ID: 21391610 [TBL] [Abstract][Full Text] [Related]
17. Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK). MacKinnon CH; Lau K; Burch JD; Chen Y; Dines J; Ding X; Eigenbrot C; Heifetz A; Jaochico A; Johnson A; Kraemer J; Kruger S; Krülle TM; Liimatta M; Ly J; Maghames R; Montalbetti CA; Ortwine DF; Pérez-Fuertes Y; Shia S; Stein DB; Trani G; Vaidya DG; Wang X; Bromidge SM; Wu LC; Pei Z Bioorg Med Chem Lett; 2013 Dec; 23(23):6331-5. PubMed ID: 24138940 [TBL] [Abstract][Full Text] [Related]
18. Structure-based design of PDK1 inhibitors. Poulsen A; Blanchard S; Soh CK; Lee C; Williams M; Wang H; Dymock B Bioorg Med Chem Lett; 2012 Jan; 22(1):305-7. PubMed ID: 22119465 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening. Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158 [TBL] [Abstract][Full Text] [Related]
20. Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV. Nordhoff S; Cerezo-Gálvez S; Deppe H; Hill O; López-Canet M; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A Bioorg Med Chem Lett; 2009 Aug; 19(15):4201-3. PubMed ID: 19515557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]